SKYE BIOSCIENCE INC. - COMMON STOCK
1.8200
25-April-25 16:45:00
15 minutes delayed
Stocks
+0.0300
+1.68%
Today's range
1.7500 - 1.9200
ISIN
N/A
Source
NASDAQ
-
Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences
26 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 Aug 2024 18:45:36 By Nasdaq GlobeNewswire
-
22 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights
09 Aug 2024 17:59:37 By Nasdaq GlobeNewswire
-
Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th
11 Jul 2024 07:15:00 By Nasdaq GlobeNewswire
-
11 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Bioscience Appoints Dr. Karen Smith to Board of Directors
03 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes
01 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye BioScience Participating in Piper Sandler Virtual Obesity Day
25 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program
10 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Bioscience to Present at Jefferies Global Healthcare Conference
03 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
10 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Skye Bioscience to Present at Upcoming Investment Conferences
23 Apr 2024 07:00:00 By Nasdaq GlobeNewswire